Cargando…

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion

BACKGROUND: Drug-disease interactions negatively affect the benefit/risk ratio of drugs for specific populations. In these conditions drugs should be avoided, adjusted, or accompanied by extra monitoring. The motivation for many drug-disease interactions in the Summary of Product Characteristics (Sm...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Tongeren, Justine M. Z., Harkes-Idzinga, S. Froukje, van der Sijs, Heleen, Atiqi, Roya, van den Bemt, Bart J. F., Draijer, L. Willem, Hiel, Deline, Kerremans, Adrian, Kremers, Bart, de Leeuw, Marc, Olthoff, Marleen V., Pham, T. Kim-Loan, Valentijn-Robertz, Ricky, Tsoi, Kayan, Wichers, Iris, de Wit, Maaike, Borgsteede, Sander D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243438/ https://www.ncbi.nlm.nih.gov/pubmed/32499701 http://dx.doi.org/10.3389/fphar.2020.00707

Ejemplares similares

Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

Safe use of proton pump inhibitors in patients with cirrhosis
por: Weersink, Rianne A., et al.
Publicado: (2018)

The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies
por: Berger, Florine A., et al.
Publicado: (2021)

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice
por: Berger, Florine A., et al.
Publicado: (2020)

Dynamics of the QTc interval over a 24‐h dose interval after start of intravenous ciprofloxacin or low‐dose erythromycin administration in ICU patients
por: Berger, Florine A., et al.
Publicado: (2021)

Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial
por: Wientjes, Maike H. M., et al.
Publicado: (2021)

European Society of Clinical Pharmacy definition of the term clinical pharmacy and its relationship to pharmaceutical care: a position paper
por: Dreischulte, Tobias, et al.
Publicado: (2022)

Unintended consequences of reducing QT-alert overload in a computerized physician order entry system
por: van der Sijs, Heleen, et al.
Publicado: (2009)

Informational needs of general practitioners regarding discharge medication: content, timing and pharmacotherapeutic advices
por: Karapinar, Fatma, et al.
Publicado: (2010)

Even low alcohol concentrations affect obstacle avoidance reactions in healthy senior individuals
por: Hegeman, Judith, et al.
Publicado: (2010)

A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping
por: Pouls, Bart PH, et al.
Publicado: (2022)

Development of a context model to prioritize drug safety alerts in CPOE systems
por: Riedmann, Daniel, et al.
Publicado: (2011)

Formal algorithmic elimination for PDEs
por: Robertz, Daniel
Publicado: (2014)

Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program
por: Papastergiou, John, et al.
Publicado: (2020)

Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors
por: Gieling, Job, et al.
Publicado: (2022)

The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients
por: Karapinar-Çarkıt, Fatma, et al.
Publicado: (2010)

Barriers and facilitators to disease-modifying antirheumatic drug use in patients with inflammatory rheumatic diseases: a qualitative theory-based study
por: Voshaar, Marieke, et al.
Publicado: (2016)

Evaluation of the feasibility of screening for paediatric non‐alcoholic fatty liver disease
por: Draijer, Laura, et al.
Publicado: (2022)

PELICAN: A quality of life instrument for childhood asthma: Study Protocol of two Randomized Controlled Trials in Primary and Specialized Care in the Netherlands
por: van Bragt, Stephanie, et al.
Publicado: (2012)

The Effect of Self-Administration of Medication During Hospitalization on Patient’s Self-Efficacy and Medication Adherence After Discharge
por: van Herpen-Meeuwissen, Loes J M, et al.
Publicado: (2022)

Does a Dose Calculator as an Add-On to a Web-Based Paediatric Formulary Reduce Calculation Errors in Paediatric Dosing? A Non-Randomized Controlled Study
por: van der Zanden, Tjitske M., et al.
Publicado: (2020)

Tele-monitoring flares using a smartphone app in patients with gout or suspected gout: a feasibility study
por: Pouls, Bart P H, et al.
Publicado: (2021)

Electronic Monitoring Feedback for Improving Medication Adherence and Clinical Outcomes in Early Rheumatoid Arthritis: A Randomized Clinical Trial
por: van Heuckelum, Milou, et al.
Publicado: (2021)

Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey
por: Bekker, Charlotte, et al.
Publicado: (2019)

Community Pharmacy-Based eGFR Screening for Early Detection of CKD in High Risk Patients
por: Papastergiou, John, et al.
Publicado: (2020)

Determinants of drug prices: a systematic review of comparison studies
por: Janssen Daalen, Jules M, et al.
Publicado: (2021)

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
por: van den Bemt, Bart JF, et al.
Publicado: (2011)

The effect of Patient’s Own Medication use on patient’s self-reported medication knowledge during hospitalisation: a pre-post intervention study
por: van Herpen-Meeuwissen, Loes J. M., et al.
Publicado: (2022)

Usability and perceived usefulness of patient-centered medication reconciliation using a personalized health record: a multicenter cross-sectional study
por: van der Nat, Denise J., et al.
Publicado: (2022)

Smarter Sediment Screening: Effect-Based Quality Assessment, Chemical Profiling, and Risk Identification
por: de Baat, Milo L., et al.
Publicado: (2019)

Psychosocial predictors of non-adherence to chronic medication: systematic review of longitudinal studies
por: Zwikker, Hanneke E, et al.
Publicado: (2014)

An Insiders’ Outside Perspective on the Flemish-Walloon Conflict: The Role of Identification and Disidentification for the German-Speaking Minority
por: Asbrock, Frank, et al.
Publicado: (2017)

Beliefs of rheumatologists and general practitioners on urate lowering therapy: a cross-sectional study
por: Veenstra, Frouwke, et al.
Publicado: (2023)

Matching Adherence Interventions to Patient Determinants Using the Theoretical Domains Framework
por: Allemann, Samuel S., et al.
Publicado: (2016)

Diagnostic accuracy of a single‐lead portable ECG device for measuring QTc prolongation
por: Bekker, Charlotte L., et al.
Publicado: (2019)

Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis
por: Zwikker, Hanneke E, et al.
Publicado: (2014)

Finding Meaning Amidst COVID-19: An Existential Positive Psychology Model of Suffering
por: Van Tongeren, Daryl R., et al.
Publicado: (2021)

Disentangling Rheumatoid Arthritis Patients’ Implicit and Explicit Attitudes toward Methotrexate
por: Linn, Annemiek J., et al.
Publicado: (2016)

Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis
por: Mathijssen, Elke GE, et al.
Publicado: (2018)

Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective
por: van Lint, Jette A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h1afa63bbdqvhf5phm8tij3eg8